Dihexa
Last updated: 1/23/2026 Last reviewed: 1/23/2026
At a Glance
Dihexa is a research compound discussed in the context of neurotrophic signaling and cognition. Robust human outcome data and a well-defined safety profile are not established.
⚠️ Research Status: This dossier is an intake stub pending literature curation. It is not medical advice. Protocol/dosing guidance is intentionally not included.
Intake Notes (Unreviewed)
- Tags (from internal sheet): Longevity; Cognitive function
- Reported adverse effects (unverified): anxiety; change of taste; insomnia; irritability; mood swings; nausea
Mechanism of Action (TBD)
Often described as engaging pathways related to HGF/c-Met signaling (needs primary sources).
Evidence Summary
Low Confidence ReviewLiterature curation pending.
Safety & Unknowns
- CNS-active research compounds can have unpredictable effects across individuals.
- Reported adverse effects above are unverified and may not be complete.
Regulatory Status
| Region | Status |
|---|---|
| United States (FDA) | Not approved |
| European Union (EMA) | Not approved |
| WADA | Check current list (status may change) |
Changelog
| Date | Change |
|---|---|
| 2026-01-23 | Added intake stub from compounds sheet |